Hendrickson-Rebizant T, Sudhakar S, Rowley M, Frankel A, Davie J, Lakowski T
J Med Chem. 2024; 67(18):15931-15946.
PMID: 39250434
PMC: 11440505.
DOI: 10.1021/acs.jmedchem.4c00490.
Wang S, Klein S, Urban S, Staudt M, Barthes N, Willmann D
Nat Commun. 2024; 15(1):43.
PMID: 38167811
PMC: 10762027.
DOI: 10.1038/s41467-023-44243-6.
Brown T, Nguyen T, Zhou B, Zheng Y
RSC Chem Biol. 2023; 4(9):647-669.
PMID: 37654509
PMC: 10467615.
DOI: 10.1039/d3cb00018d.
Iyamu I, Al-Hamashi A, Huang R
Biomolecules. 2021; 11(6).
PMID: 34201091
PMC: 8230315.
DOI: 10.3390/biom11060854.
Gao Y, van Haren M, Moret E, Rood J, Sartini D, Salvucci A
J Med Chem. 2019; 62(14):6597-6614.
PMID: 31265285
PMC: 6713424.
DOI: 10.1021/acs.jmedchem.9b00413.
Chemical Biology of Protein N-Terminal Methyltransferases.
Huang R
Chembiochem. 2018; 20(8):976-984.
PMID: 30479015
PMC: 6465133.
DOI: 10.1002/cbic.201800615.
Revealing inhibition difference between PFI-2 enantiomers against SETD7 by molecular dynamics simulations, binding free energy calculations and unbinding pathway analysis.
Niu Y, Shi D, Li L, Guo J, Liu H, Yao X
Sci Rep. 2017; 7:46547.
PMID: 28417976
PMC: 5394549.
DOI: 10.1038/srep46547.
Induction of Epigenetic Alteration by CPUK02, An Ent- kaurenoid Derivative of Stevioside.
Mokarram P, Mohammadi Z, Khazayel S, Dayong Z
Avicenna J Med Biotechnol. 2017; 9(1):13-18.
PMID: 28090275
PMC: 5219816.
Facile synthesis of SAM-peptide conjugates through alkyl linkers targeting protein -terminal methyltransferase 1.
Zhang G, Huang R
RSC Adv. 2016; 6(8):6768-6771.
PMID: 27588169
PMC: 5004777.
DOI: 10.1039/C5RA20625A.
Small Molecule Inhibitors of Protein Arginine Methyltransferases.
Hu H, Qian K, Ho M, Zheng Y
Expert Opin Investig Drugs. 2016; 25(3):335-58.
PMID: 26789238
PMC: 4929062.
DOI: 10.1517/13543784.2016.1144747.
Structural biology and chemistry of protein arginine methyltransferases.
Schapira M, Ferreira de Freitas R
Medchemcomm. 2015; 5(12):1779-1788.
PMID: 26693001
PMC: 4655611.
DOI: 10.1039/c4md00269e.
Protein Arginine Methylation and Citrullination in Epigenetic Regulation.
Fuhrmann J, Thompson P
ACS Chem Biol. 2015; 11(3):654-68.
PMID: 26686581
PMC: 4802296.
DOI: 10.1021/acschembio.5b00942.
Design of a fluorescent ligand targeting the S-adenosylmethionine binding site of the histone methyltransferase MLL1.
Luan Y, Blazer L, Hu H, Hajian T, Zhang J, Wu H
Org Biomol Chem. 2015; 14(2):631-638.
PMID: 26541578
PMC: 4689628.
DOI: 10.1039/c5ob01794g.
SAM/SAH Analogs as Versatile Tools for SAM-Dependent Methyltransferases.
Zhang J, Zheng Y
ACS Chem Biol. 2015; 11(3):583-97.
PMID: 26540123
PMC: 5772741.
DOI: 10.1021/acschembio.5b00812.
Chemical biology of protein arginine modifications in epigenetic regulation.
Fuhrmann J, Clancy K, Thompson P
Chem Rev. 2015; 115(11):5413-61.
PMID: 25970731
PMC: 4463550.
DOI: 10.1021/acs.chemrev.5b00003.
Discovery of a Dual PRMT5-PRMT7 Inhibitor.
Smil D, Eram M, Li F, Kennedy S, Szewczyk M, Brown P
ACS Med Chem Lett. 2015; 6(4):408-12.
PMID: 25893041
PMC: 4394339.
DOI: 10.1021/ml500467h.
Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors.
Zhang G, Richardson S, Mao Y, Huang R
Org Biomol Chem. 2015; 13(14):4149-54.
PMID: 25712161
PMC: 4857722.
DOI: 10.1039/c5ob00120j.
Targeting chromatin to improve radiation response.
Olcina M, Odell S, Hammond E
Br J Radiol. 2014; 88(1047):20140649.
PMID: 25513745
PMC: 4651187.
DOI: 10.1259/bjr.20140649.
Epigenetic control of gene function in schistosomes: a source of therapeutic targets?.
Cabezas-Cruz A, Lancelot J, Caby S, Oliveira G, Pierce R
Front Genet. 2014; 5:317.
PMID: 25309576
PMC: 4159997.
DOI: 10.3389/fgene.2014.00317.
Bromo-deaza-SAH: a potent and selective DOT1L inhibitor.
Yu W, Smil D, Li F, Tempel W, Fedorov O, Nguyen K
Bioorg Med Chem. 2013; 21(7):1787-1794.
PMID: 23433670
PMC: 4780262.
DOI: 10.1016/j.bmc.2013.01.049.